Marriott International (Nasdaq: MAR) reported a higher profit and flat revenues for the first quarter of 2019. While earnings topped the street view, revenues missed. The management provided its earnings and revenue guidance for the second quarter and fiscal 2019.
Earnings of the Maryland-based hotel franchiser, on an adjusted basis, advanced 5% to $1.41 per share in the first quarter from $1.34 per share a year earlier. Earnings also surpassed the Street view. Reported profit dropped to $375 million or $1.09 per share from $420 million or $1.16 per share in the first quarter of 2018.
Meanwhile, revenues were broadly unchanged from last year at $5.01 billion. The market’s expectation was for a higher top-line number.
“Despite modest RevPAR growth and higher labor costs, we increased North American house profit margins by 30 basis points and held worldwide house profit margins flat at our company-operated hotels through cost synergies, leading to strong incentive management fee performance in the quarter,” said CEO Arne Sorenson.
Overall comparable RevPAR, a measure of revenues generated from room occupancy, rose 1.1% globally, on a constant currency basis. RevPAR grew 0.8% in North America and 1.9% elsewhere. During the three-month period, Marriott added around 19,000 rooms.
Overall comparable RevPAR, a measure of revenue from room occupancy, rose 1.1% globally in the quarter, on a constant currency basis
For the second quarter, the company expects earnings in the range of $1.52 per share to $1.58 per share. Gross fee revenues are estimated to be between $0.99 billion and $1.01 billion. The forecast for operating income is $770-$795 million.
The management is looking for full-year earnings between $5.97 per share and $6.19 per share and gross fee revenues in the range of $3.85 billion to $3.93 billion. Operating income is estimated to be in the $2.93-$3.03 billion range. The guidance, meanwhile, fell short of Wall Street’s prediction.
Shares of Marriott closed the last trading session slightly higher. The stock has gained 26% so far this year and is currently trading slightly above the $135-mark.
Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on